Overview

The Effects of Sedatives on Tobacco Use Disorder Version 2

Status:
Not yet recruiting
Trial end date:
2026-12-31
Target enrollment:
Participant gender:
Summary
Double-blind, placebo-controlled, randomized mechanistic clinical trial to test a single intravenous dose of ketamine or an active control (midazolam) on cigarette smoking behavior, craving, and neural effects.
Phase:
Early Phase 1
Details
Lead Sponsor:
Wake Forest University Health Sciences
Treatments:
Ketamine
Midazolam